or GlaxoSmithKline, has announced that it has agreed to settle nearly 80,000 state-level Zantac cases. The lawsuits claimed that the now-discontinued version of the heartburn drug caused cancer ...

Pfizer has agreed to settle more than 10,000 lawsuits which alleged that ... in the summer of 2022 after concerns about ...

GSK has reached ... 93% of the outstanding lawsuits brought against the company claiming that its gastrointestinal drug Zantac caused cancer. The company has agreed to pay $2.2 billion to settle ...

GSK has opted to settle a key lawsuit in its defence against claims that its Zantac drug caused cancer, rather than proceed with a jury trial. The company said this morning it had reached a ...

To apply for a cash advance lawsuit loan from your anticipated GSK Zantac lawsuit settlement, please visit the company's website HERE or call 877.571.0405. Settlement monies are not expected ...

GSK’s shares ... slightly lower after it agreed a $2.2 billion settlement over lawsuits in the US, which alleged the drugmaker’s now-discontinued heartburn drug Zantac triggered cancer.

GSK last month agreed to settle about 80,000 Zantac lawsuits, representing most of the litigation against it, for $2.2 billion. Pfizer has also agreed to settle most of the outstanding cases ...

GSK PLC on Wednesday agreed to pay up to USD2.2 billion to settle the vast majority of cases linked to its heartburn ... Subscribe now to see this Premium News article from Alliance News ...